Safe Haven Clinical Research (SHCR) was founded in 2022 by two cousins from Mississippi.  Collectively, they have worked over 20 years in the medical and pharmaceutical industry.  

One founder, unfulfilled with industry norms, lost parents and a grandfather prematurely from complications due to cancer.  As a result of these losses, she vowed to become a game changer in the medical field.  She has devoted her life to helping companies create better and more innovative medicines.  In return, the side effects of these medicines will be less harsh on patients. 

Both founders envisioned a world-class, pharmaceutical clinical trial company that would also aid companies in marketing new products.  This goal lead to collaborations with biopharmaceutical companies, government entities, universities, and academic medical centers.  SHCR prides itself on building collaborative relationships, facilitating change in poverty-stricken areas, and delivering on commitments.